{"date":"2025-05-14","count":22,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6499-2025-05-14-2336-h72jq2","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"23:36:37","subject":"本公司接獲Terumo提出「里程碑放棄通知」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-14 23:36，「本公司接獲Terumo提出「里程碑放棄通知」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-14-2135-p9bs5i","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"21:35:29","subject":"公告本公司重要營運主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-14 21:35，「公告本公司重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-14-2134-b9gsdb","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"21:34:00","subject":"公告本公司員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-14 21:34，「公告本公司員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-14-2132-14yeswy","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"21:32:29","subject":"本公司董事會決議修訂114年股東常會召集事由(新增討論事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-14 21:32，「本公司董事會決議修訂114年股東常會召集事由(新增討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-14-2127-1rawt61","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"21:27:28","subject":"公告本公司獨立董事任期達三屆繼續提名之說明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-14 21:27，「公告本公司獨立董事任期達三屆繼續提名之說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-14-2126-jpizg6","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"21:26:10","subject":"公告本公司董事會決議發行員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-14 21:26，「公告本公司董事會決議發行員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-14-2124-9qofud","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"21:24:43","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-14 21:24，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-05-14-1944-4xocq9","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"19:44:16","subject":"本公司子公司Foresee Pharmaceuticals USA, Inc.公告ALDH2活化劑mirivadelgat（FP-045）用於治療間質性肺病引起之肺高壓二期臨床試驗首位受試者給藥","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-05-14 19:44，「本公司子公司Foresee Pharmaceuticals USA, Inc.公告ALDH2活化劑mirivadelga」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-05-14-1845-eyg2sl","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"18:45:58","subject":"本公司受邀參加花旗環球證券之2025Q1線上法說會議","clause":"第12款","fact_date":"2025-05-15","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-05-14 18:45，「本公司受邀參加花旗環球證券之2025Q1線上法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-05-14-1823-16wnc9","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-05-14","time":"18:23:55","subject":"代子公司 ENIMMUNE-RMT BIOTECH PTE. LTD.公告董事會決議通過辦理現金減資案","clause":"第9款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-05-14 18:23，「代子公司 ENIMMUNE-RMT BIOTECH PTE. LTD.公告董事會決議通過辦理現金減資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-05-14-1736-ozqyjx","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-05-14","time":"17:36:36","subject":"本公司受邀參加國票綜合證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-05-14 17:36，「本公司受邀參加國票綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-05-14-1730-1vm80eh","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"17:30:56","subject":"公告本公司114年第一次辦理私募現金增資發行普通股之定價日、發行價格及增資基準日等相關事項","clause":"第11款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-05-14 17:30，「公告本公司114年第一次辦理私募現金增資發行普通股之定價日、發行價格及增資基準日等相關事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-05-14-1730-1oq17s0","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"17:30:27","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"第31款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-05-14 17:30，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-14-1704-hgl4pt","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-14","time":"17:04:13","subject":"本公司民國114年度第一季合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-14 17:04，「本公司民國114年度第一季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-05-14-1644-11vxjjv","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"16:44:24","subject":"本公司114年現金增資股款催繳公告","clause":"第53款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-05-14 16:44，「本公司114年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-05-14-1609-1pu04cw","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-05-14","time":"16:09:40","subject":"(更正召集事由項次)公告本公司董事會決議召開114年第一次股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-05-14 16:09，「(更正召集事由項次)公告本公司董事會決議召開114年第一次股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-05-14-1606-z0re09","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-05-14","time":"16:06:11","subject":"公告本公司董事會通過114年度第一季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-05-14 16:06，「公告本公司董事會通過114年度第一季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-14-1600-8hqjh3","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"16:00:20","subject":"本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-14 16:00，「本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-05-14-1550-9qofud","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"15:50:43","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-05-14 15:50，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-05-14-1547-17893oj","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"15:47:55","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"第31款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-05-14 15:47，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-05-14-1519-1jw01z","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-05-14","time":"15:19:11","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio (HK) Limited","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-05-14 15:19，「代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio (HK) Limited」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-05-14-1433-g6i1u0","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-14","time":"14:33:49","subject":"更正本公司114Q1XBRL合併財報申報資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-05-14 14:33，「更正本公司114Q1XBRL合併財報申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}